The latest closing stock price for Kymera Therapeutics as of November 20, 2024 is 44.05.
An investor who bought $1,000 worth of Kymera Therapeutics stock at the IPO in 2020 would have $324 today, roughly 0 times their original investment - a 7.28% compound annual growth rate over 4 years.
The all-time high Kymera Therapeutics stock closing price was 87.83 on December 28, 2020.
The Kymera Therapeutics 52-week high stock price is 53.27, which is 20.9% above the current share price.
The Kymera Therapeutics 52-week low stock price is 18.89, which is 57.1% below the current share price.
The average Kymera Therapeutics stock price for the last 52 weeks is 37.96.
An investor who bought $1,000 worth of Kymera Therapeutics stock at the IPO in 2020 would have $324 today, roughly 0 times their original investment - a 7.28% compound annual growth rate over 4 years.
The all-time high Kymera Therapeutics stock closing price was 87.83 on December 28, 2020.
The Kymera Therapeutics 52-week high stock price is 53.27, which is 20.9% above the current share price.
The Kymera Therapeutics 52-week low stock price is 18.89, which is 57.1% below the current share price.
The average Kymera Therapeutics stock price for the last 52 weeks is 37.96.